Evidence map›Paper›PMID 21512855›Full record

ArticleMycopathologia2011

Uncommon fungi isolated from diabetic patients toenails with or without visible onychomycoses.

Marisela González-Avila, Juan Vicente Gómez-Gómez, Alejandra Paula Espinosa Texis, José Luis Imbert-Palafox, Marco Antonio Becerril-Flores, José Luis Blasco

Abstract read
PubMed Publisher
In one paragraph

Article in Mycopathologia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Onychomycosis in special populations.Future microbiology · 2025
    Review
  3. Article
  4. Successful Treatment ofInfection and drug resistance · 2025
    Article
  5. Article
  6. Frontiers in microbiology · 2021
    Review
  7. [Infections of finger and toe nails due to fungi and bacteria].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2014
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Marisela González-AvilaBiotechnology Area, Universidad Politécnica de Pachuca, Zempoala, Hidalgo, Mexico.
Juan Vicente Gómez-Gómez
Alejandra Paula Espinosa Texis
José Luis Imbert-Palafox
Marco Antonio Becerril-Flores
José Luis Blasco
Universidad Autónoma del Estado de Hidalgo · MXBenemérita Universidad Autónoma de Puebla · MXSecretaría de Salud de Jalisco · MXUniversidad Politécnica de Pachuca · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kodamaea ohmeri and Prototheca wickerhamii are rare pathogens for humans, and even more rare as cause of onychomycosis. This work reports the second case of onychomycosis by K. ohmeri and the fourth of onycoprotothecosis; it was made in public health institutions in the Hidalgo State, Mexico, studying 261 diabetic patients during 2005 and 2006. Kodamaea ohmeri was isolated from toenails of a 51-year-old female patient, and P. wickerhamii from three female patients of 48, 49, and 61 years old, respectively, all of them with type 2 diabetes mellitus (DM 2). Identifications were done by standard microbiological methods and a commercial system. Only one patient infected with P. wickerhamii showed mixed infection with dermatophytes. Out of the total studied DM 2 patients, 1.15% presented onycoprotothecosis and 0.38% onychomycosis by K. ohmeri, high percentages if it is considered that few cases have been reported of K. ohmeri and P. wickerhamii as onychomycosis causal agents.

Indexed as

Diabetes ComplicationsAdultAgedAged, 80 and overFemaleFungiHumansMaleMexicoMiddle AgedNailsOnychomycosisSaccharomycetales

Identifiers

PMID21512855
OpenAlexW2010481031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.